Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

Search for leo pharma in registrations and monthly communication reports

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (10)
Results: 1-10 | Export
  1. LEO PHARMA INC.
    Type: In-house Corporation
    Responsible officer: Jill Archibald, General Manager
    Registration: 8 of 8 (2023-10-03 to present)
    Posted: 2023-10-03
    Subject matter details: 1
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  2. LEO PHARMA INC.
    Type: In-house Corporation
    Responsible officer: Jill Archibald, General Manager
    Registration: 7 of 8 (2022-10-31 to 2023-10-03)
    Posted: 2022-10-31
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  3. LEO PHARMA INC.
    Type: In-house Corporation
    Responsible officer: Jill Archibald, General Manager
    Registration: 6 of 8 (2022-04-25 to 2022-10-31)
    Posted: 2022-05-27
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  4. LEO PHARMA INC.
    Type: In-house Corporation
    Responsible officer: Goncalo Goya, COUNTRY LEAD
    Registration: 5 of 8 (2021-08-16 to 2022-04-25)
    Posted: 2021-08-17
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 4
  5. LEO PHARMA INC.
    Type: In-house Corporation
    Responsible officer: Kristian Fick, COUNTRY LEAD
    Registration: 4 of 8 (2019-03-01 to 2020-06-16)
    Posted: 2019-03-01
    Subject matter details: 1
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  6. LEO PHARMA INC.
    Type: In-house Corporation
    Responsible officer: Kristian Fick, COUNTRY LEAD
    Registration: 3 of 8 (2018-10-16 to 2019-03-01)
    Posted: 2018-10-17
    Subject matter details: 1
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  7. LEO PHARMA INC.
    Type: In-house Corporation
    Responsible officer: Kristian Fick, COUNTRY LEAD
    Registration: 2 of 8 (2018-08-24 to 2018-10-16)
    Posted: 2018-09-05
    Subject matter details: 1
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  8. LEO PHARMA INC.
    Type: In-house Corporation
    Responsible officer: ALAN COLEY, DIRECTOR, REGULATORY AFFAIRS & VETERINARY BUS.
    Registration: 2 of 2 (2000-03-06 to 2001-02-28)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 3
    Communication techniques: 4
    Government funding: No
  9. LEO PHARMA INC.
    Type: In-house Corporation
    Responsible officer: GREGORY HINES, PRESIDENT
    Registration: 1 of 8 (1999-02-12 to 2000-02-29)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 8
    Communication techniques: 4
    Government funding: No
  10. LEO PHARMA INC.
    Type: In-house Corporation
    Responsible officer: ALAN COLEY, DIRECTOR, REGULATORY AFFAIRS & VETERINARY BUS.
    Registration: 1 of 2 (1999-02-12 to 2000-03-06)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 3
    Communication techniques: 4
    Government funding: No
Monthly communication reports (9)
Results: 1-9 | Export
  1. LEO PHARMA INC.
    Type: In-house Corporation
    Occurred: 2023-08-03
    Posted: 2023-10-03
    Designated public office holders:
    • Dr. Stephen Ellis, Member of Parliament | House of Commons
    Subject matters:
    • Health
      •
  2. LEO PHARMA INC.
    Type: In-house Corporation
    Occurred: 2019-12-05
    Posted: 2019-12-16
    Designated public office holders:
    • Rodrigo Arancibia, Director | Innovation, Science and Economic Development Canada (ISED)
    • Jocelyn Milburn, Officer | Innovation, Science and Economic Development Canada (ISED)
    • Mitch Davies, Sr Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
      •
  3. LEO PHARMA INC.
    Type: In-house Corporation
    Occurred: 2019-11-21
    Posted: 2019-12-16
    Designated public office holders:
    • Rodrigo Arancibia, Director | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
      •
  4. LEO PHARMA INC.
    Type: In-house Corporation
    Occurred: 2019-06-12
    Posted: 2019-07-02
    Designated public office holders:
    • David Lee, Chief Regulatory Officer | Health Canada (HC)
    Subject matters:
    • Health
      •
  5. LEO PHARMA INC.
    Type: In-house Corporation
    Occurred: 2019-05-08
    Posted: 2019-05-24
    Designated public office holders:
    • Supriya Sharma, Chief Medical Advisor, HC / Senior Medical Advisor for HPFB | Health Canada (HC)
    • Marcel Saulnier, Associate ADM | Health Canada (HC)
    Subject matters:
    • Health
      •
  6. LEO PHARMA INC.
    Type: In-house Corporation
    Occurred: 2019-02-26
    Posted: 2019-03-01
    Designated public office holders:
    • Janet MacPhee, Senior Investment Officer | Global Affairs Canada (GAC)
    • Emily Yorke, Policy Advisor | Finance Canada (FIN)
    • Arthur Lam, Sr Advisor, MINISTER OF SMALL BUSINESS AND EXPORT PROMOTION | Innovation, Science and Economic Development Canada (ISED)
    • Zoe Hawa, Deputy Director | Global Affairs Canada (GAC)
    Subject matters:
    • Health
      •
  7. LEO PHARMA INC.
    Type: In-house Corporation
    Occurred: 2018-11-16
    Posted: 2018-11-30
    Designated public office holders:
    • Joseph Wabegijig, Policy Advisor | Indigenous Services Canada (ISC)
    • Rodrigo Arancibia, Director, Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)
    • Benoit Leduc, Manager | Innovation, Science and Economic Development Canada (ISED)
    • Kate Moussouni, Senior Policy Advisor | Health Canada (HC)
    • Kate Proctor, Policy Advisor | Treasury Board Of Canada Secretariat (TBS)
    • Kevin Deagle, Policy Advisor | Indigenous Services Canada (ISC)
    Subject matters:
    • Health
      •
  8. LEO PHARMA INC.
    Type: In-house Corporation
    Occurred: 2018-10-09
    Posted: 2018-10-16
    Designated public office holders:
    • Mary Ng, Member of Parliament | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
      •
  9. LEO PHARMA INC.
    Type: In-house Corporation
    Occurred: 2018-08-27
    Posted: 2018-08-30
    Designated public office holders:
    • John Oliver, Member of Parliament | House of Commons
    Subject matters:
    • Health
      •
Date Modified: